PHIO PHARMACEUTICALS CORP
CUSIP 71880W204
Phio Pharmaceuticals Corp has 6 institutional holders in Filings Flow’s 13F database, together reporting 1.27M shares worth $392,000 as of Q3 2019. The largest reported holders are Ubs Group AG, Cvi Holdings, LLC, and Sg Americas Securities, LLC.
Institutional Holders
6
Q3 2019
Reported Value
$392,000
Ticker
unmapped
private placement or foreign
Quarters Tracked
4
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| CVI Holdings, LLC$116M AUM | 0.21% | $180,000 | 499.4K | Q3 2019OLDER |
| TWO SIGMA SECURITIES, LLC$861M AUM | 0.00% | $18,000 | 48.4K | Q2 2019OLDER |
| UBS Group AG$666.3B AUM | 0.00% | $427,000 | 45.4K | Q4 2019OLDER |
| RENAISSANCE TECHNOLOGIES LLC$63.9B AUM | 0.00% | $57,000 | 333.9K | Q4 2019OLDER |
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $33,000 | 85.6K | Q2 2019OLDER |
| HSBC HOLDINGS PLC$191.6B AUM | 0.00% | $5,000 | 29.4K | Q4 2019OLDER |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP$893.3B AUM | 0.00% | $9,000 | 33.1K | Q3 2019OLDER |
| Advisor Group, Inc.$14.5B AUM | — | $0 | 3 | Q4 2019OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.